Global Health
Why we need a new way to judge the value of medicine
We need to shift the conversation to focus on value and outcomes delivered, rather than on isolated costs of therapies, writes the CEO of Novartis.
Joseph Jimenez
1982, Bachelor's degree, Stanford; 1984, MBA, UC Berkeley. Formerly: Head, North America and Head, EU Business, Heinz. With Novartis: 2007, Head, Consumer Health; Head, Novartis Pharma, moving portfolio towards newly launched products. Since 2010, Chief Executive Officer, Novartis. Former Non-Executive Director, AZ. Adviser, Private Equity, US Blackstone Group. Member of the Board, General
Motors.
Most Popular
China
There's a research revolution going on in China – and one day it could save your life
Joseph Jimenez looks at the scientific and research revolution going on in China.
Davos Agenda
Three ways the Fourth Industrial Revolution can transform healthcare
We’ve only just begun to see the potential of medical advances in areas of innovation like genomics.
Global Governance
These are the game-changing new technologies transforming medicine
The new meaning of old age
Africa
3 ways to improve healthcare in Africa
Africa
Three priorities for better healthcare in Africa
Innovating beyond R&D
